OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
June 16, 2013
The Supreme Court decision blocking patents on naturally-occurring genes has generated predictions of doom for biotech innovation, along with expectations of more healthy competition in discovering new treatments and diagnostics.
June 02, 2013
Bills to regulate drug compounding and establish a national track and trace system face political and policy differences.
An overview of the latest regulatory developments for malaria drugs, biosimilars, and global standards.
May 30, 2013
The US Food and Drug Administration and industry have been working to incorporate process validation as an integral component of drug development and production, and to avoid divergent policies in the US and Europe.
May 02, 2013
Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.
FDA faces budget crunch; Supreme Court hears key cases